17/11/2025
Scientists have reported progress on an antibody that blocks almost every known HIV strain. The antibody targets a stable part of the virus that rarely mutates. This gives researchers a clearer path to stronger treatments. Teams at the NIH and several global labs have tested the antibody in early studies. Lab data shows broad activity across diverse HIV samples from multiple regions.
Researchers plan to begin human trials. They want to measure safety, durability, and real world protection. HIV still infects more than one million people each year. A treatment that works across strains can reduce infections and improve long term care. The findings appear in recent publications from leading virology groups.
